Platelet‐to‐lymphocyte ratio better predicts inflammation than neutrophil‐to‐lymphocyte ratio in end‐stage renal disease patients

Türkmen, Kültiğin; Mehmet Erdur, Fatih; Özçıçek, Fatih; Özçiçek, Adalet; Murat Akbaş, Emin; Ozbıcer, Aysu; Demirtaş, Levent; Türk, Süleyman; Zeki Tonbul, Halil

doi:10.1111/hdi.12040

Public

Platelet‐to‐lymphocyte ratio better predicts inflammation than neutrophil‐to‐lymphocyte ratio in end‐stage renal disease patients

Published in Hemodialysis International • Mar 24, 2013

Authors:

Kültiğin Türkmen

Fatih Mehmet Erdur

Fatih Özçıçek

Abstract

Neutrophil-to-lymphocyte ratio (NLR) was introduced as a potential marker to determine inflammation in end-stage renal disease (ESRD) patients. Recently, platelet-to-lymphocyte ratio (PLR) and NLR were found to positively correlated with inflammatory markers including tumor necrosis factor-α (TNF-α)...

Subject

Medicine

Neutrophil to lymphocyte ratio

End stage renal disease

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!